|Articles|May 15, 2023
Accelerated Delivery to a Development Candidate Enabled by RapidFire Mass Spectrometry
Author(s)Agilent Technologies
Time to results can be significantly reduced with the use of RapidFire high-throughput mass spectrometry (MS). With this technique, a lab’s next great innovation can be brought from conception to reality in a timely and efficient manner.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
3
Charles River Incubator Cohort to Accelerate CGT Development
4
Developing Next-Gen Cell Lines Using Targeted Integration
5
